FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, ...
DXCM's redesigned Stelo app is set for a July U.S. rollout, with international expansion and pediatric clearance broadening ...
Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience.
DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced at Aspen Ideas: Health a series of ...
SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users ...
Monitoring your health stats, from steps to heart rate, can help you get a handle on your fitness goals. But lately, we've seen technology that takes things a step further, enabling at-home tracking ...
In March 2024, the FDA approved the first over-the-counter continuous glucose monitors (CGMs), marking a quiet but significant shift in how we can track and understand our health. Devices like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results